DSpace at RU >

Browsing by Author Heijden, A.G. van der

Full Text	Issue Date	Title	Author(s)
	2009	Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer.	Hendricksen, K.; Heijden, A.G. van der; Cornel, E.B.; Vergunst, H.; Reijke, T.M. de, et al
	2007	The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis.	Heijden, A.G. van der; Hulsbergen- van de Kaa, C.A.; Witjes, J.A.
	2006	New treatment strategies for superficial bladder cancer	Heijden, A.G. van der
	2006	Potential and toxicity of intravesical pemetrexed: a preclinical study in pigs.	Hendricksen, K.; Moonen, P.M.J.; Heijden, A.G. van der; Molkenboer-Kuenen, J.D.M.; Hulsbergen- van de Kaa, C.A., et al
	2006	Review pathology in a diagnostic bladder cancer trial: effect of patient risk category.	Witjes, J.A.; Moonen, P.M.J.; Heijden, A.G. van der
	2006	[A man with oral ulcers caused by hypereosinophilic syndrome and a good response to the tyrosine-kinase inhibitor imatinib]	Verstappen, M.C.; Mattijssen, V.; Reijden, B.A. van der; Heijden, A.G. van der; Wahab, P.J., et al
	2006	Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response.	Heijden, A.G. van der; Moonen, P.M.J.; Cornel, E.B.; Vergunst, H.; Reijke, T.M. de, et al
	2006	False-positive lesions detected by fluorescence cystoscopy: any association with p53 and p16 expression?	Hendricksen, K.; Moonen, P.M.J.; Heijden, A.G. van der; Witjes, J.A.
	2005	Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study.	Witjes, J.A.; Moonen, P.M.J.; Heijden, A.G. van der
	2005	Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study.	Heijden, A.G. van der; Verhaegh, G.W.C.T.; Jansen, C.F.J.; Schalken, J.A.; Witjes, J.A.
	2004	Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.	Vossenaar, E.R.; Radstake, T.R.D.J.; Heijden, A.G. van der; Mansum, M.A. van; Dieteren, C.E.J., et al
	2004	Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.	Gofrit, O.N.; Shapiro, A.; Pode, D.; Sidi, A.; Nativ, O., et al
	2004	Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder.	Heijden, A.G. van der; Kiemeney, L.A.L.M.; Gofrit, O.N.; Nativ, O.; Sidi, A., et al
	2004	The rheumatoid arthritis specific Sa antigen is citrullinated vimentin	Vossenaar, E.R.; Depres, N.; Lora, M.; Heijden, A.G. van der; Lapointe, E., et al
	2004	Foot volume increase on nifedipine is not prevented by pretreatment with diuretics.	Heijden, A.G. van der; Huysmans, F.T.M.; Hamersvelt, H.W. van
	2004	The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines.	Heijden, A.G. van der; Jansen, K.F.J.; Verhaegh, G.W.C.T.; O'Donnell, M.A.; Schalken, J.A., et al
	2004	Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin	Vossenaar, E.R.; Despres, N.; Lapointe, E.; Heijden, A.G. van der; Lora, M., et al
	2004	Intravesical gemcitabine: a phase 1 and pharmacokinetic study.	Witjes, J.A.; Heijden, A.G. van der; Vriesema, J.L.J.; Peters, G.J.; Laan, A., et al
	2004	Rabip4' is an effector of rab5 and rab4 and regulates transport through early endosomes.	Fouraux, M.A.; Deneka, M.; Ivan, V.; Heijden, A.G. van der; Raymackers, J., et al
	2004	Features of the citrullinating peptidylarginine deiminase enzymes	Vossenaar, E.R.; Zendman, A.J.W.; Raijmakers, R.; Weiting, T.J.; Heijden, A.G. van der, et al